Integrated Filing — IndAS



General information about company

Scrip Code 543524
NSE Symbol RAINBOW
MSEI Symbol NOTLISTED
ISIN INE961O01016
Name of company Rainbow Children's Medicare Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 31-10-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 23-10-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment The business of running multi-specialty pediatric and obstetrics and gynecology hospital.
Start date and time of board meeting 31-10-2026   16:00:00
End date and time of board meeting 31-10-2026   18:00:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 09-02-2025
Indicate Company website link for updated RPT policy of the Company https://d31scedd5hpubp.cloudfront.net/investor_files/Policy_on_Materiality_and_Dealing_with_Related_Party_TransactionsFEB2025.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
As per results attached there are no default on loans and debt securities.



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 48,699.10 89,753.80
Other income 809.20 2,084.90
Total income 49,508.30 91,838.70
2 Expenses
(a) Cost of materials consumed 6,411.00 11,879.50
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 0.00 0.00
(d) Employee benefit expense 6,723.60 12,714.40
(e) Finance costs 1,991.40 3,916.30
(f) Depreciation, depletion and amortisation expense 3,980.90 7,743.50
(f) Other Expenses
1 Professional fees to doctors 12,424.30 23,297.30
2 Contract wages 1,317.70 2,498.60
3 Power and fuel 752.70 1,563.30
4 Canteen expenses 702.70 1,335.70
5 Business promotion and advertisement 1,184.80 2,107.00
6 Repairs and maintenance 813.70 1,407.80
7 Rates and taxes 525.50 969.40
8 Lab and investigations 585.10 989.60
9 Communication expenses 326.50 934.20
10 Other Expenses 1,781.90 3,441.50
Total other expenses 20,414.90 38,544.40
Total expenses 39,521.80 74,798.10
3 Total profit before exceptional items and tax 9,986.50 17,040.60
4 Exceptional items 0.00 0.00
5 Total profit before tax 9,986.50 17,040.60
6 Tax expense
7 Current tax 3,051.90 4,947.80
8 Deferred tax (574.70) (687.10)
9 Total tax expenses 2,477.20 4,260.70
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 7,509.30 12,779.90
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 7,509.30 12,779.90
17 Other comprehensive income net of taxes (16.60) (33.10)
18 Total Comprehensive Income for the period 7,492.70 12,746.80
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 10,156.60 10,156.60
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 7.41 12.61
Diluted earnings (loss) per share from continuing operations 7.41 12.61
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 7.41 12.61
Diluted earnings (loss) per share from continuing and discontinued operations 7.41 12.61
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) refer results uploaded



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026
Date of end of reporting period 30-09-2026
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 1,53,436.30
Capital work-in-progress 10,107.90
Investment property 0.00
Goodwill 0.00
Other intangible assets 856.00
Intangible assets under development 1,073.60
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 23,811.70
Trade receivables, non-current 0.00
Loans, non-current 6,569.30
Other non-current financial assets
1 Other non-current financial assets 5,202.30
Total of other non-current financial assets 5,202.30
Total non-current financial assets 35,583.30
Deferred tax assets (net) 4,313.70
Other non-current assets
1 Non-current tax assets (net) 1,705.50
2 Other non-current assets 4,467.00
Total of other non-current assets 6,172.50
Total non-current assets 2,11,543.30
2 Current assets
Inventories 4,004.40
Current financial asset
Current investments 29,651.90
Trade receivables, current 12,531.80
Cash and cash equivalents 1,850.10
Bank balance other than cash and cash equivalents 3.20
Loans, current 639.60
Other current financial assets
Total of other current financial assets 15,460.90
Total current financial assets 60,137.50
Current tax assets (net) 0.00
Other current assets
1 Other current assets 3,015.80
Total of other current assets 3,015.80
Total current assets 67,157.70
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 2,78,701.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 10,156.60
Other equity 1,63,841.60
Total equity attributable to owners of parent 1,73,998.20
Non controlling interest
Total equity 1,73,998.20
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 Other non-current financial liabilities 84,005.50
Total of other non-current financial liabilities 84,005.50
Total non-current financial liabilities 84,005.50
Provisions, non-current 1,838.30
Deferred tax liabilities (net) 0.00
Deferred government grants, Non-current 0.00
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 85,843.80
Current liabilities
Current financial liabilities
Borrowings, current 0.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 1,132.80
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 9,487.50
Total Trade payable 10,620.30
Other current financial liabilities
1 Other current financial liabilities 2,404.40
2 Lease liabilities 2,611.00
Total of other current financial liabilities 5,015.40
Total current financial liabilities 15,635.70
Other current liabilities 2,641.90
1 Other current liabilities 2,641.90
Total of other current liabilities 2,641.90
Provisions, current 581.40
Current tax liabilities (Net) 0.00
Deferred government grants, Current 0.00
Total current liabilities 18,859.00
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 1,04,702.80
Total equity and liabilites 2,78,701.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2026 01-04-2026
Date of end of reporting period 30-09-2026 30-09-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
Total Amount of items that will not be reclassified to profit and loss
2 Income tax relating to items that will not be reclassified to profit or loss 22.10 44.20
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss (5.50) (11.10)
5 Total Other comprehensive income (16.60) (33.10)



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026
B Date of end of reporting period 30-09-2026
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 17,040.60
Adjustments for reconcile profit (loss)
Adjustments for finance costs 3,916.30
Adjustments for decrease (increase) in inventories (1,013.80)
Adjustments for decrease (increase) in trade receivables, current (2,550.40)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 0.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current (2,165.00)
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 0.00
Adjustments for increase (decrease) in trade payables, non-current 1,878.60
Adjustments for increase (decrease) in other current liabilities 0.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 7,743.50
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 359.30
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current (17.30)
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (10.80)
Adjustments for dividend income 0.00
Adjustments for interest income 0.00
Adjustments for share-based payments 164.70
Adjustments for fair value losses (gains) (1,031.20)
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow (1,040.70)
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 58.40
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 6,291.60
Net cash flows from (used in) operations 23,332.20
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 5,283.80
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 18,048.40
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 1,851.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 1.10
Purchase of property, plant and equipment 12,305.70
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 200.00
Cash receipts from repayment of advances and loans made to other parties 200.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 423.10
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 8,487.70
Net cash flows from (used in) investing activities (5,244.80)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 4,290.10
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 25.90
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 0.00
Repayments of borrowings 0.00
Payments of lease liabilities 939.00
Dividends paid 3,554.80
Interest paid 3,923.50
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (12,681.50)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 122.10
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents 122.10
Cash and cash equivalents cash flow statement at beginning of period 1,728.00
Cash and cash equivalents cash flow statement at end of period 1,850.10





Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Rainbow Children's Medicare Limited Mr. K Ramadhar Naidu Relative of KMP Purchase of goods or services Approved by Audit Committee 32.00 5.40 6.50
2 Rainbow Children's Medicare Limited Mr. K Ramadhar Naidu Relative of KMP Any other transaction Reimbursement of expenses Approved by Audit Committee 1.90 0.20 0.00
3 Rainbow Children's Medicare Limited Rainbow Speciality Hospitals Pvt Ltd Subsidiary Purchase of goods or services Approved by Audit Committee 19.10 0.00 0.00
4 Rainbow Children's Medicare Limited Rainbow Speciality Hospitals Pvt Ltd Subsidiary Any other transaction Rent Approved by Audit Committee 21.00 0.00 0.00
5 Rainbow Children's Medicare Limited Rainbow Speciality Hospitals Pvt Ltd Subsidiary Sale of goods or services Approved by Audit Committee 43.30 0.00 0.00
6 Rainbow Children's Medicare Limited Rosewalk Healthcare Private Limited Wholly owned subsidiary Any other transaction Investment in Share Capital of Subsidiary Approved by Audit Committee 0.00 2,778.10 2,778.10
7 Rainbow Children's Medicare Limited Rosewalk Healthcare Private Limited Wholly owned subsidiary Any other transaction Accrued Interest on Inter Corporate Deposits Approved by Audit Committee 4.50 5.80 10.30
8 Rainbow Children's Medicare Limited Rosewalk Healthcare Private Limited Wholly owned subsidiary Inter-corporate deposit Approved by Audit Committee 0.00 100.00 100.00
9 Rainbow Children's Medicare Limited Rosewalk Healthcare Private Limited Wholly owned subsidiary Any other transaction Rent Approved by Audit Committee 11.40 1.90 0.70
10 Rainbow Children's Medicare Limited Rosewalk Healthcare Private Limited Wholly owned subsidiary Any other transaction Security Deposit Approved by Audit Committee 0.00 0.70 0.70
11 Rainbow Children's Medicare Limited Rosewalk Healthcare Private Limited Wholly owned subsidiary Purchase of goods or services Approved by Audit Committee 222.70 0.00 0.90
12 Rainbow Children's Medicare Limited Rosewalk Healthcare Private Limited Wholly owned subsidiary Sale of goods or services Approved by Audit Committee 142.30 281.00 0.00
13 Rainbow Children's Medicare Limited Prashanthi Medicare Private Limited Subsidiary Any other transaction Investment in Share Capital of Subsidiary Approved by Audit Committee 0.00 2,485.20 2,485.20
14 Rainbow Children's Medicare Limited Prashanthi Medicare Private Limited Subsidiary Any other transaction Investment in NCRPS (Equity Component) Approved by Audit Committee 0.00 259.50 259.50
15 Rainbow Children's Medicare Limited Prashanthi Medicare Private Limited Subsidiary Any other transaction Investment in NCRPS (Loan Component) Approved by Audit Committee 0.00 515.30 515.30
16 Rainbow Children's Medicare Limited Prashanthi Medicare Private Limited Subsidiary Interest received Approved by Audit Committee 22.90 32.80 55.70
17 Rainbow Children's Medicare Limited Prashanthi Medicare Private Limited Subsidiary Any other transaction Accrued Interest on Inter Corporate Deposits Approved by Audit Committee 15.70 16.70 3.00
18 Rainbow Children's Medicare Limited Prashanthi Medicare Private Limited Subsidiary Inter-corporate deposit Approved by Audit Committee (150.00) 400.00 250.00
19 Rainbow Children's Medicare Limited Prashanthi Medicare Private Limited Subsidiary Sale of goods or services Approved by Audit Committee 42.10 0.00 0.00
20 Rainbow Children's Medicare Limited Pratiksha Women & Child Care Hospital Private Limited Subsidiary Any other transaction Investment in Share Capital of Subsidiary Approved by Audit Committee 0.00 12,996.00 12,996.00
21 Rainbow Children's Medicare Limited Pratiksha Women & Child Care Hospital Private Limited Subsidiary Any other transaction Investment in NCRPS (Equity Component) Approved by Audit Committee 0.00 1,374.70 1,374.70
22 Rainbow Children's Medicare Limited Pratiksha Women & Child Care Hospital Private Limited Subsidiary Any other transaction Investment in NCRPS (Loan Component) Approved by Audit Committee 0.00 2,729.30 2,729.30
23 Rainbow Children's Medicare Limited Pratiksha Women & Child Care Hospital Private Limited Subsidiary Interest received Approved by Audit Committee 118.90 145.00 263.90
24 Rainbow Children's Medicare Limited Pratiksha Women & Child Care Hospital Private Limited Subsidiary Sale of goods or services Approved by Audit Committee 2.00 0.00 0.00
25 Rainbow Children's Medicare Limited Rainbow Woman and Children's Hospital Private Limited Subsidiary Any other transaction Investment in Share Capital of Subsidiary Approved by Audit Committee 0.20 1.00 0.80
26 Rainbow Children's Medicare Limited Rainbow Woman and Children's Hospital Private Limited Subsidiary Any other transaction Investment in CCD of Subsidiary Approved by Audit Committee 400.00 0.00 400.00
27 Rainbow Children's Medicare Limited Rainbow Woman and Children's Hospital Private Limited Subsidiary Inter-corporate deposit Approved by Audit Committee 40.00 0.00 40.00
28 Rainbow Children's Medicare Limited Rainbow Woman and Children's Hospital Private Limited Subsidiary Any other transaction Accrued Interest on Inter Corporate Deposits Approved by Audit Committee 0.10 0.00 0.10
29 Rainbow Children's Medicare Limited Super Prime Medical Care LLP Subsidiary Any other transaction Purchase Consideration paid for aqusition of subsidiary Approved by Audit Committee 1,984.00 0.00 1,984.00
30 Rainbow Children's Medicare Limited Super Prime Medical Care LLP Subsidiary Inter-corporate deposit Approved by Audit Committee 160.00 0.00 160.00
31 Rainbow Children's Medicare Limited Super Prime Medical Care LLP Subsidiary Any other transaction Accrued Interest on Inter Corporate Deposits Approved by Audit Committee 1.20 0.00 1.20
32 Rainbow Children's Medicare Limited Super Prime Medical Care LLP Subsidiary Sale of goods or services Approved by Audit Committee 41.80 0.00 41.80
33 Rainbow Children's Medicare Limited Rainbow Fertility Private Limited Wholly owned subsidiary Any other transaction Investment in Share Capital of Subsidiary Approved by Audit Committee 0.00 450.00 450.00
34 Rainbow Children's Medicare Limited Rainbow CRO Private Limited Wholly owned subsidiary Any other transaction Investment in Share Capital of Subsidiary Approved by Audit Committee 0.00 1.00 1.00
35 Rainbow Children's Medicare Limited Rainbow CRO Private Limited Wholly owned subsidiary Sale of goods or services Approved by Audit Committee 0.10 0.40 0.50
36 Rainbow Children's Medicare Limited Rainbow Children's Foundation Enterprises where key managerial personnel along with their relatives exercise significant influence Any other transaction IP Bills Approved by Audit Committee 45.50 0.00 17.40
37 Rainbow Children's Medicare Limited Unimed Healthcare Pvt.Ltd Enterprises where relative of key managerial personnel is a member Any other transaction Reimbursement of expenses Approved by Audit Committee 95.60 13.00 63.10
38 Rainbow Children's Medicare Limited Unimed Healthcare Pvt.Ltd Enterprises where relative of key managerial personnel is a member Sale of goods or services Approved by Audit Committee 2.50 3.70 6.20
39 Rainbow Children's Medicare Limited Unimed Healthcare Pvt.Ltd Enterprises where relative of key managerial personnel is a member Purchase of goods or services Approved by Audit Committee 156.00 23.30 0.20
40 Rainbow Children's Medicare Limited Unimed Healthcare Pvt.Ltd Enterprises where relative of key managerial personnel is a member Any other transaction Security Deposit Approved by Audit Committee 0.00 300.00 300.00
41 Rainbow Children's Medicare Limited Unimed Healthcare Pvt.Ltd Enterprises where relative of key managerial personnel is a member Any other transaction Rent Approved by Audit Committee 272.20 49.00 49.00
42 Rainbow Children's Medicare Limited Dr. Ramesh Kancharla Chairman and Managing Director Any other transaction Travel Advance Approved by Audit Committee 0.00 13.30 13.30
43 Rainbow Children's Medicare Limited Dr. Ramesh Kancharla Chairman and Managing Director Remuneration Approved by Audit Committee 325.00 0.00 0.00
44 Rainbow Children's Medicare Limited Dr. Dinesh Kumar Chirla Whole Time Director Purchase of goods or services Approved by Audit Committee 169.00 25.20 25.60
45 Rainbow Children's Medicare Limited Dr. Sai Aishwarya Chirla Relative of KMP Purchase of goods or services Approved by Audit Committee 4.10 0.70 0.00
46 Rainbow Children's Medicare Limited Rainbow Children's Hospital Foundation Enterprises where key managerial personnel exercise significant influence Any other transaction CSR Approved by Audit Committee 25.80 0.00 0.00
47 Rainbow Children's Medicare Limited Rainbow Children's Hospital Foundation Enterprises where key managerial personnel exercise significant influence Any other transaction CSR on-going Approved by Audit Committee 299.40 0.00 0.00
48 Rainbow Children's Medicare Limited Ms. Shreya Mitra Compliance Officer Advance Approved by Audit Committee (0.80) 0.80 0.00
49 Rainbow Children's Medicare Limited Mr.Vikas Maheshwari Chief Financial Officer Any other transaction Investment in Equity Share capital NA 0.70 1.30 2.10 Textual Information(1)
50 Rainbow Children's Medicare Limited Mr. K Ramadhar Naidu Relative of KMP Any other transaction Investment in Equity Share capital NA (0.30) 6.00 5.70 Textual Information(2)
51 Rainbow Children's Medicare Limited Mr.Vikas Maheshwari Chief Financial Officer Dividend paid Approved by Audit Committee 0.70 0.00 0.00
52 Rainbow Children's Medicare Limited Dr. Ramesh Kancharla CMD of the Company Dividend paid Approved by Audit Committee 1,103.10 0.00 0.00
53 Rainbow Children's Medicare Limited Dr. Dinesh Kumar Chirla WTD of the Company Dividend paid Approved by Audit Committee 232.20 0.00 0.00
54 Rainbow Children's Medicare Limited Dr. Adarsh Kancharla Relative of KMP Dividend paid Approved by Audit Committee 213.90 0.00 0.00
55 Rainbow Children's Medicare Limited Mr. K Ramadhar Naidu Relative of KMP Dividend paid Approved by Audit Committee 2.10 0.00 0.00
56 Rainbow Children's Medicare Limited Dr. Adarsh Kancharla Non-executive Director Any other transaction Board Sitting fees Approved by Audit Committee 3.50 0.00 0.00
57 Rainbow Speciality Hospitals Private Limited Dr. Nageswar Rao K Director Purchase of goods or services Approved by Audit Committee 75.00 0.00 0.00
58 Rosewalk Healthcare Private Limited Prashanthi Medicare Private Limited Sister Concern Any other transaction Rent Approved by Audit Committee 0.30 0.00 0.00
59 Rosewalk Healthcare Private Limited Pratiksha Women & Child Care Hospital Private Limited Sister Concern Any other transaction Rent Approved by Audit Committee 1.20 0.00 0.00
60 Rosewalk Healthcare Private Limited Pratiksha Women & Child Care Hospital Private Limited Sister Concern Sale of goods or services Approved by Audit Committee 0.70 0.00 0.00
61 Pratiksha Women & Child Care Hospital Private Limited Coras Pratiksha Orthopaedic Hospital Director of PWCCHPL is Partner in Coras Sale of goods or services Approved by Audit Committee 228.40 58.10 45.90
62 Pratiksha Women & Child Care Hospital Private Limited Coras Pratiksha Orthopaedic Hospital Director of PWCCHPL is Partner in Coras Purchase of goods or services Approved by Audit Committee 44.00 2.90 0.70
63 Pratiksha Women & Child Care Hospital Private Limited Prathiksha Medicos Director of PWCCHPL is Partner in Medicos Purchase of goods or services Approved by Audit Committee (1.70) 1.70 0.00
64 Pratiksha Women & Child Care Hospital Private Limited Pratiksha Hospitals Private Limited Common Director Any other transaction Rent Approved by Audit Committee 94.50 0.00 0.00
65 Pratiksha Women & Child Care Hospital Private Limited Prathiksha Day Care Centre Director of PWCCHPL is Partner in Prathiksha Day Care Centre Any other transaction Rent Approved by Audit Committee 94.50 0.00 0.00
66 Pratiksha Women & Child Care Hospital Private Limited PRAMOD KUMAR SHARMA Director Any other transaction Rent Approved by Audit Committee 4.50 0.00 0.00
67 Pratiksha Women & Child Care Hospital Private Limited PRAMOD KUMAR SHARMA Director Purchase of goods or services Approved by Audit Committee 3.50 0.00 0.00
68 Pratiksha Women & Child Care Hospital Private Limited Structures and Earthquake Director of PWCCHPL is Partner in Structures and Earthquake Purchase of goods or services Approved by Audit Committee 7.70 1.80 0.00
69 Prashanthi Medicare Private Limited Prashanthi Macha Director Any other transaction Rent Approved by Audit Committee 75.00 0.00 0.00
70 Prashanthi Medicare Private Limited Prashanthi Macha Director Purchase of goods or services Approved by Audit Committee 36.00 0.00 0.00
71 Rainbow Children's Medicare Limited Rainbow Speciality Hospitals Pvt Ltd Subsidiary Any other transaction Investment in Share Capital of Subsidiary Approved by Audit Committee 0.00 1,425.10 1,425.10
72 Super Prime Medical Care LLP Kethu Venkata Ajithreddy Partner Purchase of goods or services Approved by Audit Committee 12.10 0.00 8.00
73 Super Prime Medical Care LLP Alwarusetty Kalyana Chakravarthy Partner Purchase of goods or services Approved by Audit Committee 12.10 0.00 8.00
74 Super Prime Medical Care LLP Talupuru Venkata Nagaraju Partner Purchase of goods or services Approved by Audit Committee 12.10 0.00 8.00
75 Super Prime Medical Care LLP Kethu Venkata Ajithreddy Partner Any other transaction Rent Approved by Audit Committee 1.20 0.00 1.20
76 Super Prime Medical Care LLP Alwarusetty Kalyana Chakravarthy Partner Any other transaction Rent Approved by Audit Committee 1.20 0.00 1.20
77 Super Prime Medical Care LLP Talupuru Venkata Nagaraju Partner Any other transaction Rent Approved by Audit Committee 1.20 0.00 1.20
Total value of transaction during the reporting period 6,830.90



Text Block

Textual Information(1) Allotment pursuant to ESOP (RSU)
Textual Information(2) Sale of shares pursuant to pre-clearance